baber/WOPTO huggingface dataset:
Patent AU-2010204991-A1 (AU)
Title: Continuous semicontinuous and batch methods for treating liquids and manufacturing certain constituents (e.g., nanoparticles) in liquids, apparatuses and nanoparticles and nanoparticle/liquid solution(s) and colloids resulting therefrom
Inventor: PIERCE DAVID K
IPC: B22F9/20
Filed: 2010-01-13
Abstract: This invention relates generally to novel methods and novel devices for the continuous manufacture of nanoparticles, microparticles and nanoparticle/liquid solution(s) (e.g., colloids). The nanoparticles (and/or micron-sized particles) comprise a variety of possible compositions, sizes and shapes. The particles (e.g., nanoparticles) are caused to be present (e.g., created and/or the liquid is predisposed to their presence (e.g., conditioned)) in a liquid (e.g., water) by, for example, preferably utilizing at least one adjustable plasma (e.g., created by at least one AC and/or DC power source), which plasma communicates with at least a portion of a surface of the liquid. At least one subsequent and/or substantially simultaneous adjustable electrochemical processing technique is also preferred. Multiple adjustable plasmas and/or adjustable electrochemical processing techniques are preferred. Processing enhancers can be utilized alone or with a plasma. Semicontinuous and batch processes can also be utilized. The continuous processes cause at least one liquid to flow into, through and out of at least one trough member, such liquid being processed, conditioned and/or effected in said trough member(s). Results include constituents formed in the liquid including ions, micron-sized particles and/or nanoparticles (e.g., metallic-based nanoparticles) of novel size, shape, composition, concentration, zeta potential and certain other novel properties present in a liquid.
Patent AU-2010205834-A1 (AU)
Title: Improved cabling system and method for monitoring and managing physically connected devices over a data network
Inventor: SHAY YOSSEF
IPC: H04Q1/14
Filed: 2010-01-14
Abstract: The present invention relates to a method and system configured to monitor devices that are physically connected over a data network, said system comprising at least one scanner configured to monitor said data network and to determine devices that are physically connected over said data network, said at least one scanner being connected to at least one panel over said data network, wherein at least one terminal of each panel is connected to an electronic circuitry, which comprises one or more electronic components, for enabling said at least one scanner to determine changes in one of voltage or current level over at least one of said one or more electronic components, said changes occurring due to connecting or disconnecting devices over said data network, thereby enabling said at least one scanner to monitor devices that are physically connected over said data network.
Patent AU-2010208274-A1 (AU)
Title: Oligomer-phenothiazine conjugates
Inventor: XUYUAN GU
IPC: A61K47/48
Filed: 2010-01-28
Abstract: The invention relates to (among other things) oligomer-phenothiazine conjugates and related compounds. A conjugate of the invention, when administered by any of a number of administration routes, exhibits advantages over un-conjugated phenothiazine compounds.
Patent AU-2010214093-A1 (AU)
Title: Energy absorbing and displacing structure for athletic protective equipment
Inventor: Brian Kamradt
IPC: A41D13/00
Filed: 2010-02-02
Abstract: An energy absorbing and displacing structure for athletic protective equipment, such as an athletic shin-guard, is provided using a flexible web-shaped body to hold a rigid band-shaped member in place. The inner rigid band-shaped member follows the contour of the desired area to protect. The outer flexible web-shaped body is made of a softer rubber like material and works as a locator and supporter keeping the inner, rigid band-shaped member, in proper location.
Patent AU-2010241526-A1 (AU)
Title: RNA sequence-specific mediators of RNA interference
Inventor: BARTEL DAVID P
IPC: C12N/
Filed: 2010-11-18
Abstract: The present invention relates to a Drosophila in vitro system which was used to demonstrate that dsRNA is processed to RNA segments 21-23 nucleotides (nt) in length. Furthermore, when these 21-23 nt fragments are purified and added back to Drosophila extracts, they mediate RNA interference in the absence of long dsRNA. Thus, these 21-23 nt fragments are the sequence-specific mediators of RNA degradation. A molecular signal, which may be their specific length, must be present in these 21-23 nt fragments to recruit cellular factors involved in RNAi. This present invention encompasses these 21-23 nt fragments and their use for specifically inactivating gene function.; The use of these fragments (or chemically synthesized oligonucleotides of the same or similar nature) enables the targeting of specific mRNAs for degradation in mammalian cells, where the use of long dsRNAs to elicit RNAi is usually not practical, presumably because of the deleterious effects of the interferon response. This specific targeting of a particular gene function is useful in functional genomic and therapeutic applications.
Patent AU-2010249455-A1 (AU)
Title: Removable toilet seat barrier
Inventor: LORANNE EHLENBACH
IPC: A47K13/18
Filed: 2010-05-21
Abstract: A toilet seat barrier is disclosed that may be rotatably supported by a spindle to allow a user to apply the toilet seat barrier on a toilet seat surface without touching the toilet seat. An adhesive is provided on the bottom side of the toilet seat barrier to releasably secure the toilet seat barrier to the toilet seat surface. Perforations may be formed along a length of the toilet seat barrier so that the barrier may be sized to the seat. Further, tabs may be formed on the top side of the toilet seat barrier to allow a user to remove of the toilet seat barrier without touching the seat.
Patent AU-2010254200-A1 (AU)
Title: Benzoxazepines as inhibitors of PI3K/m TOR and methods of their use and manufacture
Inventor: NAING AAY
IPC: C07D487/08
Filed: 2010-05-25
Abstract: The invention is directed to Compounds of Formula (I): the invention provides compounds that inhibit, regulate, and/or modulate P13K and/or mTOR that are useful in the treatment of hyperproliferative diseases, such as cancer, in mammals. This invention also provides methods of making the compound methods of using such compounds in the treatment of hyperproliferative diseases in mammals, especially humans, and to pharmaceutical compositions containing such compounds. For example, cancer in which activity against PI3fC-alph mTOR, or both contributes to its pathology and/or symptomatology include breast cancer mantle cell lymphoma, renal cell carcinoma, acute myelogenous leukemia, chronic myelogenous leukemia, NPM/ALK- transformed anaplastic large cell lymphoma, diffu large B cell lymphoma, rhabdomyosarcoma, ovarian cancer, endometrial cancer, cervic cancer, non small cell lung carcinoma, small cell lung carcinoma, adenocarcinoma, col cancer, rectal cancer, gastric carcinoma, hepatocellular carcinoma, melanoma, pancreat cancer, prostate carcinoma, thyroid carcinoma, anaplastic large cell lymphoma, hemangiom glioblastoma, or head and neck cancer.
Patent AU-2010256522-A1 (AU)
Title: Systems and methods for through-the-earth communications
Inventor: MARSHALL DAVID L
IPC: H04B13/02
Filed: 2010-06-03
Abstract: Systems and methods for wirelessly sending signals through the earth between transmitting and receiving antennas are disclosed, wherein the communicating antennas are of the types that generate significant far field radiation and may interact substantially through the emission and absorption of electromagnetic radiation in addition to magnetic coupling. Frequencies are typically chosen which may be much higher than those conventionally used for through-the-earth (TTE) communications. In many situations where TTE communication is desired, the electromagnetic coupling and associated magnetic coupling produced and utilized by these certain types of antennas provide greater effective communications ranges when compared with the ranges that are obtainable with antennas interacting predominately by magnetic coupling alone.
Patent AU-2010264557-A1 (AU)
Title: Definition of control data for automatic control of mobile mining machine
Inventor: LEHTINEN ANTTI
IPC: G05D1/02
Filed: 2010-06-23
Abstract: The present invention relates to a method for arranging automatic control of a mobile mining machine equipped with a bucket. The method comprises generating a general-purpose bucket emptying model that defines at least the path of the bucket of the mining machine for emptying it. The bucket emptying model is stored on a memory means. The bucket emptying model is fetched from the memory means in response to a need to define emptying the bucket for the route. At least data defining the path of the bucket in the fetched bucket emptying model are appended to the path data for use in the automatic control of the mining machine.
Patent AU-2010269976-A1 (AU)
Title: Method of forming a photonic crystal material
Inventor: VULPIUS GUNTHER
IPC: C30B5/00
Filed: 2010-07-07
Abstract: A method is provided of forming a film of photonic crystal material. A first process is performed upon a material capable of having a photonic crystal structure, this process causing deformation of the material so as to form a film in which incident light received by the material is selectively reflected or transmitted to generate a first optical effect in the film. A second process is performed upon substantially all of the film which applies a shear stress to the film. This causes a change in the material structure so as to generate a second optical effect in the film, different from the first optical effect, in response to incident light. Security films, devices, articles and documents formed using the method are also discussed.
Patent AU-2010272370-A1 (AU)
Title: Biomarker for gastrointestinal cancer
Inventor: MORGAN RICHARD
IPC: C12Q1/68
Filed: 2010-07-13
Abstract: Described are gastrointestinal cancer specific biomarkers comprising the nucleic acid sequence of the Engrailed-2 (EN2) gene or the amino acid sequence of the encoded EN2 protein. Also described are uses of the biomarkers in the treatment, diagnosis, monitoring and imaging of gastrointestinal cancer.
Patent AU-2010289618-A1 (AU)
Title: Ketorolac tromethamine compositions for treating or preventing ocular pain
Inventor: FARNES ELDON QUINN
IPC: A61K9/00
Filed: 2010-08-31
Abstract: The present invention provides an aqueous ophthalmic solution comprising an effective amount of ketorolac which comprises carboxymethyl cellulose in an aqueous solution which provides increased visual acuity in users and wherein said concentration of carboxymethyl cellulose is selected to provide an increased absorption of ketorolac in the eye of a patient which is at least 130% greater than the absorption of a comparative aqueous ketorolac ophthalmic solution having the same concentration of ketorolac.
Patent AU-2010325240-A1 (AU)
Title: Device for securing railway lines
Inventor: DAHLHAUG JAN ERIK
IPC: A01K3/00
Filed: 2010-09-20
Abstract: The device (20, 30) for securing railway tracks, which is formed by railway sleepers (11) to which parallel rails (12) are placed, on which track running vehicles such as trains, city light rails, trams, etc., traffic. The device (20, 30) is designed to prevent animals or humans from loitering on the tracks. The device (20, 30) includes elevations (21) which stretch between the rails (12). The elevations (21) are placed permanently on or integrated into the railway sleepers (11, 20), or the elevations (21) are placed between the conductor rails (22) that are attached to the sleepers (11, 20). The elevations (21) are placed at reciprocal distances and form elevations on the tracks which make it uncomfortable for humans and animals to walk on them.
Patent AU-2010331175-A1 (AU)
Title: Novel antiplatelet agent
Inventor: SATO HIROSHI
IPC: A61K31/444
Filed: 2010-12-17
Abstract: Disclosed are novel anti-platelet agents and novel compounds which can be active ingredients of the novel anti-platelet agents. Specifically disclosed is an anti-platelet agent which contains a compound represented by formula I or a pharmacologically acceptable salt thereof as an active ingredient. (In the formula, X represents N or CR; X-X may be the same or different and each represents a nitrogen atom or a carbon atom; R-R may be the same or different and each represents a hydrogen atom, an optionally substituted alkyl group, an optionally substituted alkoxy group, an optionally substituted alkylthio group, an alkenyl group, a cycloalkyl group, a halogen group, a cyano group, a hydroxyl group, or an amino group which may be substituted by one or two alkyl groups; R represents an optionally substituted aryl group or an optionally substituted heteroaryl group; and R represents an optionally substituted aryl group or an optionally substituted heteroaryl group.)
Patent AU-2010332387-A1 (AU)
Title: Method for correcting pathological configurations of segments of the lower extremities and device for realizing same
Inventor: CHUGUNOV VITALY VIKTOROVICH
IPC: A61F5/00
Filed: 2010-12-10
Abstract: The invention relates to a method for the step-by-step correction of the position of the longitudinal axes of segments of the lower extremities in the horizontal and/or frontal and/or sagittal planes, that comprises the simultaneous dosed correction of the imbalance of forces in the muscles supporting the corresponding joints, the reduction of the pathological configurations of said segments, and the fixation of corrected segments using at least one module of a modular exoskeleton capable of individual adjustment for bringing, during each step, the position of the longitudinal axis of each segment closer to the physiologically correct position, and for permitting movements about the corrected rotation axes of the joints within a predetermined range defined by said modular exoskeleton. The proposed device for correcting pathological configurations of segments of the lower extremities comprises a modular exoskeleton, the modules of which can be used independently or in various combinations. The modular exoskeleton comprises at least one adjustable pelvis belt (1, 47), at least one means (3, 51) for holding the thigh in a given position, at least one means (4, 89) for rotating the tibia, at least one means (5, 121) for holding the tibia in a given position, at least one means (6, 130) for correcting the position of the foot and the movement range thereof at the foot-tibia joint, at least one means (7, 146) for accommodating the foot, and a set of fixation members each in the form of a cylindrical rod (8, 9, 10, 11, 37, 52, 83, 90, 124, 141, 142) capable of linear positioning movement and/or rotation and/or free linear movement.
Patent AU-2010334808-A1 (AU)
Title: Plants tolerant to HPPD inhibitor herbicides
Inventor: POREE FABIEN
IPC: A01H5/00
Filed: 2010-12-22
Abstract: The present invention relates to nucleic acid sequences encoding a hydroxyphenylpyruvate dioxygenase (EC 1.13.11.27, abbreviated herein as HPPD) obtained from protists belonging to the family Blepharismidae, as well as the proteins encoded thereby, and to a chimeric gene which comprises such nucleic acid sequence, and to the use of such nucleic acid sequences, proteins or chimeric genes for obtaining plants which are tolerant to HPPD inhibitor herbicides.
Patent WO-2011088522-A1 (WO)
Title: Battery separator having z-dimension spacing beads and method of making same
Inventor: WINTER ALEXANDER RUDOLF
IPC: H01M50/457
Filed: 2011-01-25
Abstract: A separator for a flowing electrolyte battery and a method of making a separator for a flowing electrolyte battery. The separator comprises a separator sheet (305) made of a separator material, the separator sheet (305) having a front surface (300) and a back surface (400). A plurality of spacing beads (310), made of a spacing material that is different from the separator material, is attached to the front surface (300) and extends away from the separator sheet (305).
Patent WO-2012061893-A1 (WO)
Title: Dispositif de suspension de chaussettes
Inventor: KHOURY EDWARD JOSEPH
IPC: A47G25/14
Filed: 2011-11-11
Abstract: L'invention concerne un dispositif de suspension de chaussettes
(10) comprenant un élément allongé (14) et une pluralité de parties saillantes (18, 19, 22, 23) qui s'étendent vers l'extérieur à partir de l'élément allongé (14) et auxquelles des chaussettes peuvent être accrochées. Une partie formant un corps (40) est présente ; elle comporte une première partie latérale (42) qui s'étend vers l'extérieur à partir d'un premier côté de l'élément allongé (14) et une deuxième partie latérale (43) qui s'étend vers l'extérieur à partir de l'élément allongé (14) sur un deuxième côté opposé. Une ouverture (28) est présente dans une extrémité distale de la première partie latérale (42) de la partie formant un corps (40) et une languette (29) s'étend vers l'extérieur à partir de la deuxième partie latérale (43) de la partie formant un corps (40). La languette (29) peut être introduite dans l'ouverture (28) d'un dispositif de suspension de chaussettes adjacent (10) pour raccorder les dispositifs de suspension de chaussettes (10) l'un à l'autre.
Patent AU-2011202054-A1 (AU)
Title: Sensor arrangement for temperature measurement, and method for the measurement
Inventor: JAN CUYPERS
IPC: G01K1/00
Filed: 2011-05-04
Abstract: SENSOR ARRANGEMENT FOR TEMPERATURE MEASUREMENT, AND METHOD FOR THE MEASUREMENT Abstract s Sensor arrangement for temperature measurement in melts, in particular in metal or cryolite melts having a melting point above 600*C, with a container (7), which has on its top side an opening and in which a temperature sensor is arranged, wherein the temperature sensor has a tube (6) projecting into the container, in which tube an optical fiber (9) is arranged, which optionally has a jacket tube contacting its jacket surface, 10 wherein the tube or the jacket tube is closed on its end arranged in the container. Figure 3a ft-5 9i.3
Patent AU-2011202211-A1 (AU)
Title: User interface for medical diagnosis
Inventor: CHERNILO JONATHAN
IPC: G06Q50/00
Filed: 2011-05-12
Abstract: A user interface 10, configured to be installed in a computing apparatus, for medical diagnosis, includes a display arrangement for displaying an image 28 of a part of a patient's body on a display device of the apparatus, the image 28 including an abnormality associated with that part of the patient's body. A library of representations 52-58 is accessible by a user, the representations 52-58 depicting abnormalities associated with that part of the body, at least some of the representations 52-58 being able to be displayed on the display arrangement. A selection means is operable by the user for selecting one of the representations and for overlying the selected representation 52-58 on the image 28 to enable the user to identify the abnormality.
Patent AU-2011204898-A1 (AU)
Title: Nucleotide-cochleate compositions and methods of use
Inventor: MANNINO RAPHAEL J
IPC: A61K9/127
Filed: 2011-07-21
Abstract: The present invention is directed to cochicate compositions that include a nucleotide. The nucleotide may generally be bound via a linker to a component of the 5 cochleate, or to a lipophilic tail. Additionally or alternatively, the nucleotide may be associated with a transfection agent. The present invention also includes methods for making and using the compositions provided herein.
Patent AU-2011210227-A1 (AU)
Title: Process for the preparation of Temsirolimus and its intermediates
Inventor: GUPTA NITIN
IPC: C07D498/18
Filed: 2011-01-20
Abstract: Intermediates, process for their preparation and their use in the preparation of therapeutically effective antineoplastic agents, in particular Temsirolimus of formula (I).
Patent AU-2011232400-A1 (AU)
Title: Mechanically competent scaffold for rotator cuff and tendon augmentation
Inventor: LAURENCIN CATO T
IPC: A61B17/11
Filed: 2011-03-24
Abstract: A device has been developed to augment the rotator cuff tendon tissue as it proceeds in healing. The device has two purposes: to provide initial stability to the rotator cuff repair site to allow early mobilization of the upper extremity of the patient, and to allow for reinforcement of rotator cuff tendon repairs to increase the likelihood of successful rotator cuff tendon repairs. The device consists of an inter-connected, open pore structure that enables even and random distribution and in-growth of tendon cells. The braided structure allows for distribution of mechanical forces over a larger area of tissue at the fixation point(s).
Patent AU-2011234532-A1 (AU)
Title: Process for the purification of a Growth Factor Protein
Inventor: GILLJAM GUSTAV
IPC: B01D15/36
Filed: 2011-03-30
Abstract: A process of purifying a Growth Factor Protein in a purification sequence employing chromatography characterized in that: - at least one chromatography is performed using a multimodal resin; - the Growth Factor Protein binds to the multimodal resin at a pH between 4 to 6.2, and the Growth Factor Protein is eluting at a pH > 6.3, and the elution of Growth Factor Protein is improved by addition of arginine and/or NaCI to the eluting buffer. - The multimodal resin step is followed by a yeast derived affinity ligand resin step, which results of a purity of the product >90%.
Patent AU-2011236017-A1 (AU)
Title: System for supplemental tensioning for enhanced platform design and related methods
Inventor: PALLINI JOE
IPC: E21B17/01
Filed: 2011-10-13
Abstract: SYSTEM FOR SUPPLEMENTAL TENSIONING FOR ENHANCED PLATFORM DESIGN AND RELATED METHODS Riser management systems (30), apparatus, and methods to maintain a selected range of tension on a plurality of risers (21) extending between subsea well equipment (23) and a floating vessel (25), are provided. A riser management system (30) can include a mono-buoyancy can platform (31) operably coupled to a plurality of risers (21) extending between subsea well equipment (23) and a moored floating vessel (25), and a plurality of tensioner units (51) each connected to a top portion of a separate one of the risers (21) to provide tension to each of the risers (21). The mono-buoyancy can platform (31) can provide tension to each of the risers (21) sufficient to compensate for a relative vertical offset between the risers (21) and the vessel (25) due to vessel movement, which generally affects each of the risers (21) equally, within tolerances, while the tensioner units (51) can simultaneously provide tension to compensate for one or more additional factors which can affect each riser (21) differently. - -- 51 - - - 51 t 3 1 33 29
Patent AU-2011240678-A1 (AU)
Title: Authentication process using search technology
Inventor: CIUREA PETER
IPC: G06F17/30
Filed: 2011-04-12
Abstract: Systems and methods are presented for improved authentication and risk analysis processes using search engine technology. In one potential implementation, an authorization request message is received at a payment processing network as part of a transaction between a user and a merchant. The payment processing network analyzes risk based on a search history associated with the user involved in the transaction with the merchant. A response to the authentication request is made based in part on the risk associated with the user search history. In further embodiments, a user registers with a search engine as part of a service for improved authentication, where the user accepts privacy settings allowing storage of search and transaction data by a search engine server. The search engine server passes search and transaction data to a risk analysis server for creation of risk parameters which may be used to authenticate transactions.